期刊文献+

488例肾上腺意外瘤住院患者临床特征及诊疗 被引量:4

Clinical research of 488 inpatients with adrenal incidentaloma
下载PDF
导出
摘要 目的:分析肾上腺意外瘤(adrenal incidentaloma,AI)的临床特点和诊治现状。方法:回顾性分析2012年1月至2018年12月在北京大学第一医院住院,符合AI诊断标准的488例患者病例资料。结果:①488例AI患者中,326例(66.80%)为体检发现,409例(83.81%)为无功能占位;②180例经手术治疗的AI患者中,27例(15.00%)病理诊断为嗜铬细胞瘤,甲氧基去甲肾上腺素(normetanephrine,NMN)诊断效力曲线下面积为0.906,灵敏度为92.9%,特异度为81.6%,约登指数为0.745;计算机断层扫描(computed tomography,CT)联合血去甲肾上腺素、尿去甲肾上腺素诊断曲线下面积为0.828,敏感度为77.8%,特异度为85.3%,约登指数为0.631;③评估隔夜1 mg地塞米松抑制试验对亚临床库欣综合征(subclinical Cushing’s syndrome,SCS)的诊断价值,抑制后皮质醇最佳切点为2.1μg/dL,曲线下面积为0.967,敏感度为93.3%,特异度为92.4%,约登指数为0.857;④65例无功能AI随访半年至7年,2例进展为SCS;⑤31例<1 cm的肾上腺占位,仅2例(6.45%)为原醛症。结论:①2/3的AI为常规体检发现,是意外瘤发病率增加的主要原因,84%为无功能占位;②CT联合血、尿去甲肾上腺素诊断嗜铬细胞瘤的价值不及血NMN;③隔夜1 mg地塞米松抑制试验诊断SCS的最佳切点为2.1μg/dL,优于1.8μg/dL;④无功能AI有进展为亚临床库欣可能;⑤<1 cm的肾上腺占位功能评价意义不大,可能仅需影像学随访。 Objective:To analyze the clinical characteristics and current status of diagnosis and treatment of adrenal incidentaloma(AI).Methods:Clinical data of 488 patients admitted to Peking University First Hospital who met the AI diagnostic criteria from January 2012 to December 2018 were retrospectively analyzed.Results:①Of the 488 AI patients,326 cases(66.80%)were found during physical examination,409 cases(83.81%)were non-functional lesion.②There were 180 cases received surgical treatment,among which 27 patients(15.00%)were pathologically diagnosed as pheochromocytoma.The area under curve of blood normetane-phrine(NMN)in the diagnosis of pheochromocytoma was 0.906,with the sensitivity of 92.9%,the specificity of 81.6%,and the Youden’s index of 0.745.The area under curve of the joint test by computed tomography(CT),blood norepinephrine(NE)and urine NE was 0.828,with the sensitivity of 77.8%,the specificity of 85.3%,and the Youden’s index of 0.631.③To evaluate the diagnostic value of overnight 1 mg dexamethasone inhibition test for subclinical Cushing’s syndrome(SCS),the area under curve of the 1 mg overnight dexamethasone inhibition test in diagnosis of SCS was 0.967,the optimal cut-off point was 2.1μg/dL,with the sensitivity of 93.3%,the specificity of 92.4%,and the Youden’s index of 0.857.④A total of 65 patients of non-functional AI were followed up for 6 months to 7 years,and only 2 cases progressed to SCS.⑤There were 31 additional cases of adrenal mass<1 cm,and only 2 cases(6.45%)were primary aldosteronism.Conclusion:①Two thirds of AI was found by routine physical examination,which was the main reason for the increase of incidence of accidental tumor,and 84%of which was non-functional lesions.②The value of CT combined with blood NE and urine NE in the diagnosis of pheochromocytoma is lower than that of blood NMN.③The optimal cut-off point for the 1 mg overnight dexamethasone inhibition test diagnosis of SCS is 2.1μg/dL,which is better than 1.8μg/dL.④Non-functional AI may progress to SCS.⑤The clinical significance of adrenal lesions<1 cm function evaluation is unlikely to require,while imaging follow-up may be only required.
作者 赵乃蕊 袁戈恒 张俊清 Zhao Nairui;Yuan Geheng;Zhang Junqing(Department of Endocrinology,Cangzhou Central Hospital;Department of Endocrinology,Peking University First Hospital)
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2022年第6期652-656,共5页 Journal of Chongqing Medical University
基金 河北省卫健委医学科学研究课题计划资助项目(编号:20200306)
关键词 肾上腺意外瘤 亚临床库欣综合征 嗜铬细胞瘤 原发性醛固酮增多症 地塞米松抑制试验 adrenal incidentaloma subclinical Cushing’s syndrome pheochromocytoma primary aldosteronism dexamethasone inhibition test
  • 相关文献

参考文献3

二级参考文献35

  • 1祝宇,王卫庆,沈永倩,吴瑜璇,张翀宇,芮文斌,周文龙,孙福康,刘定益,邵远,沈周俊,毕宇芳,苏颋为,姜蕾,宁光.嗜铬细胞瘤术前的高血压控制与术中高容量血液稀释[J].临床泌尿外科杂志,2006,21(8):571-573. 被引量:3
  • 2曾正陪.肾上腺髓质疾病[A].史轶蘩主编.协和内分泌和代谢学:第1版[C].北京:科学出版社,1999.1222-1244.
  • 3Androulakis Ⅱ, Kaltsas G, Piaditis G, et al. The clinical significance of adrenal incidentalomas [ J ]. Eur J Clin Invest, 2011,41:552-560.
  • 4Griffing GT. A-I-D-S : the new endocrine epidemic [ J ]. J Clin Endocrinol Metab, 1994,79 : 1530-1531.
  • 5Zeiger MA, Thompson GB, Duh QY, et al. The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guildlines for the management of adrenal incidentalomas [ J ]. Endocr Pract, 2009,15 Suppl 1 : 1- 20.
  • 6Zeiger MA, Siegelman SS, Hamrahian AH, et al. Medical and surgical evaluation and treatment of adrenal incidentalomas [ J ]. J Clin Endocrinol Metab ,2011,96,2004-2015.
  • 7Terzolo M, Stigliano A, Chiodini I, et al. AME position statement on adrenal incidentaloma [ J ]. Eur J Endocrinol, 2011,164,851 - 870.
  • 8Bin X, Qing Y, Linhui W, et al. Adrenal incidentalomas : Experience from a retrospective study in a Chinese population[ J]. Urol Onco1,2011,29 :270-274.
  • 9Cawood TJ,Hunt PJ,O'Shea D,et al. Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant, time for a rethink .9 [ J ]. Eur J Endocrino1,2009 ,161:513-527.
  • 10曾正陪.嗜铬细胞瘤.见:陈家伦,主编.临床内分泌学[M].上海:上海科学技术出版社,2011.63744.

共引文献140

同被引文献22

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部